Nomination committee appointed
As per specifications set at Meda’s 2010 annual general meeting, a nomination committee has been appointed. It consists of:
Karl-Magnus Sjölin, Committee Chairman, Stena Sessan Rederi AB
Bert Åke Eriksson, Meda’s Chairman of the Board, Stena Sessan Rederi AB
Carina Tovi, Swedbank Robur funds
Peter Rudman, Nordea’s funds
Hans Ek, SEB funds
If questions, please contact:
Karl-Magnus Sjölin, Committee Chairman, ph. +46 31-774 35 35
Anders Larnholt, Vice President Corporate Development & IR, ph: +46 709-458 878
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.